Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Kristine McCluskey

Kristine McCluskey

Baylor College of Medicine USA

Reza Nassiri

Reza Nassiri

Michigan State University USA

Maria José Figueras

Maria José Figueras

University Rovira Virgili Spain

Natalie Borg

Natalie Borg

Monash University Australia

Kristina Miller

Kristina Miller

Fisheries and Ocean Canada

Elsie Uduak Mbuk

Elsie Uduak Mbuk

Nigerian Defence Academy Nigeria

Eunwoo Yoo

Eunwoo Yoo

Sheikh Khalifa Specialty Hospital UAE

David Blihar

David Blihar

Saint George University Grenada

Influenza 2019

About Conference

We are hereby pleased to invite all the participants from all over the world to attend the “5th International Conference on Influenza and Zoonotic Diseases” going to be held on June 17-18, 2019 at Rome, Italy. The conference includes prompt presentations, special sessions, workshops, symposium, oral talks, poster presentations and exhibitions. We expect your kind presence at the conference which will discuss and sharing their knowledge and research in the field of Influenza, Zoonotic and other infectious diseases which have become progressively important to Public Health.

Why to Attend?

Influenza-2019 highlights the theme “Research Redefined: New horizons in mitigation of Influenza and Zoonotic Diseases” which focuses knowledge and research in the field of Influenza, Zoonotic diseases and also other infectious diseases which have become progressively important to Public Health.

Influenza-2019 provides two days discussions on methods and strategies related to Influenza and Zoonotic diseases as well as explore new ideas and concepts on a global scale. This two day event provides a perfect platform for leading scientists, researchers, scholars, practitioners, health care experts, treatment providers, public health professionals, community health educators, members of academia, and other allied health professionals.

The target audiences for this event are physicians and nurses with a special emphasis on infectious diseases, public health professionals, community health educators, members of academia, and other allied health professionals.

Conference Series is an open resource platform that conducts 3000+ global events including International conferences, workshops, symposia, trade shows, exhibitions and science congresses in all the major scientific disciplines, including clinical, medical, and pharmaceutical, engineering, technology, business management and life sciences across America, Europe, The Middle East, and Asia Pacific.

Other Reasons:

  • World Class Speakers and Fresh New Talent from across the Globe in Health Industry
  • Packed Schedule: Workshops, Multi-track Conference, Expo area and more...
  • To educate yourself on the diagnosis and treatment of Influenza and Zoonotic diseases.
  • To enhance your ability to treat the growing number of patients affected by these diseases.
  • To network with your fellow primary care clinicians.
  • To empower yourself to fill the void created by the national shortage of participants.

Target Audience

  •  Microbiologists    
  •  Virologists
  •  Epidemiologists
  •  Health care professionals
  •  Research scholars Vaccinologists
  •  Immunologists
  •  Virologists
  •  Health-Care Professionals
  •  Researchers and Scientists
  •  Training Institutes
  •  Universities and Colleges Students
  •  Associations and Societies
  •  Pharmaceutical and Healthcare Companies
  •  Business Entrepreneurs
  •  Medical colleges
  •  Infectious Diseases Researchers
  •  Viral Diseases Researchers

The conference tracks are set to cover various perceptions of researches involved with Influenza and Zoonotic Diseases control measures. This would help to accommodate every possible researchers working on Zoonotic Diseases to help build a vivid picture about this common infectious disease. We will have speakers, poster sessions and workshops designed to represent the talks from experts and students.

For Scientific Sessions please go through the link:

For Abstract Submission please go through the link:

Tracks and Sessions

Track 1: Influenza Pandemic

Flu pandemics have wave nature; in 1918-1919, 1889-1990 pandemics, the flu was observed in three to four waves with increased mortality. In 1918, deadly strain of influenza A virus resulted in the pandemic; Spanish flu which was a subtype of H1N1 strain. It lasted from 1918-1920. Estimates show that around 40-50 million people were killed in the pandemic while new estimates shoew that around 50-100 million people died. It was considered as “greatest holocaust in history” which was responsible for mortality of people similar to that of the “Black Death”

Track 2: Influenza Virus

Seasonal influenza normally known as "flu", is an irresistible sickness caused by a flu infection. Side effects can be gentle to extreme. The most widely recognized manifestations include: a high fever, runny nose, sore throat, muscle torments, cerebral pain, hacking, and feeling tired. It can be hard to recognize the regular cool and flu in the beginning times of these diseases. Flu is a blend of side effects of normal cool and pneumonia, body hurt, cerebral pain, and weariness. Looseness of the bowels isn't regularly a side effect of flu in adults,[12] despite the fact that it has been found in some human instances of the H5N1 "bird flu" and can be a manifestation in children.

Track 3: Immunology and Genetic Features

RNA viruses from the Orthomyxoviridae family are responsible for the Flu. All the influenza viruses consists of eight single negative stranded RNA segments as their genome. These segments are encapsulated in protein capsids. The capsid consists of antigenic glycoproteins Neuraminidase (NA) and Hemagglutinin(HA); parts of virus which are recognized by the host immune system to generate an immune response. Due to variations in HA and NA proteins, human immune system have many challenges to create immune response.

Track 4: Clinical Impact and Diagnostic Approaches

Precise and early finding of flu viral contaminations are basic for fast commencement of antiviral treatment to lessen flu related harshness and mortality both among regular plagues and pandemics. A few distinct methodologies are at present accessible for determination of flu diseases in people. These incorporate viral release in cell culture, immunofluorescence measures, nucleic corrosive enhancement tests, immunochromatography-based fast indicative tests, and so on. More current symptomatic methodologies are being created to conquer the constraints related with a portion of the traditional identification strategies.

Track 5: Stature of Influenza Vaccine

Flu jabs, Flu shots or commonly known as influenza vaccine protect against influenza infection. The viral structure changes very rapidly, hence the vaccine is prepared twice a year, but the effectiveness of vaccine varies from year to year. According to CDC, vaccination helps in reducing the deaths, sickness, hospitalizations etc. effect of vaccine on children younger than 2 years and on individuals above 65 years is still unknown due to lack of research

Track 6: Anti-influenza drugs

Antiviral drugs are effective only if they are given at early stages, it can help inn reducing the risk of severe complications. Many viruses are capable of developing resistance against these drugs which lead to loss in efficacy of drugs. A vast range of drugs is available now against influenza, but it is not in clinical use yet. The anti-influenza drugs target the viral components as they are not subject to genetic variation. Side effects of these anti-viral drugs still remain as a disadvantage.

Track 7: Monitoring and Regulation

In influenza virus, a continuous antigenic drift is observed. To overcome this, vaccines have to be designed periodically for wild type of influenza viruses along with the different emerging strains of the virus which are found in the particular season. Pandemic preparedness which can occur from antigenic shifts

Track 8: Zoonotic diseases

Infections which are transmitted to humans through animals are known as zoonotic diseases. Above 60% of the diseases which we are infected are zoonotic. The diseases range from mild such as stomach illnesses to fatal such as rabies. Many of the illness are due to contaminated food materials, especially of animal origin food like meat which is consumed raw or not cooked properly. Influenza, the H1N1 strain is also zoonotic. The origin of these diseases is mostly animals but eventually gets transferred to humans.

Track 9: Emerging zoonotic diseases

Many factors are responsible for the emergence of zoonotic diseases which include environment associated with the pathogens and their hosts that act as their reservoirs. The factors responsible for these are farming practices modernization, destruction of habitat, climate change and human encroachment. Increase in emergence of zoonotic diseases around the globe has resulted in increased recognition of emergence of the disease. With the help of new technologies, sensitivity and the scope of the detection and diagnostic ability is expanded. Although this is true, but the pathogen may go unrecognized if there is no substantial outbreak of the disease.

Track 10: Case study of various zoonotic diseases

Numerous zoonotic illnesses are anything but difficult to treat or counteract yet in creating countries particularly general wellbeing frameworks are not all around arranged for observing, diagnosing and treating these sicknesses. Fundamental cleanliness is a critical method to lessen dangers, particularly in circumstances where individuals and creatures come into close contact. This incorporates commercial centers, homesteads, zoos and – on account of dangers from pets – in the home. Seekers and shoppers of bramble meat may likewise be at higher dangers Journalists who cover zoonotic maladies should take care to be precisely when writing about danger. Stories recognizing with infection are of extraordinary enthusiasm to the general population subsequently writers should dependably pass on the data. Many zoonotic diseases are exceptionally basic in nature, yet to a great degree uncommon.

Track 11: Molecular biology of zoonotic diseases

The human pathogens that are currently in the healthcare concern and are originated from wild or domestic animals before they are adapted in humans. Pathogens that have the ability to infect various hosts are commonly seen emerging in human population. Therefore it is necessary to understand the genetic variation in the viruses which are capable of circulating in both humans and animals to understand cross species transmission of the diseases.

Track 12: Veterinary science

Zoonotic diseases can be transferred from animals to humans and hence both the veterinary and medical communities should work hand in hand for research, public and healthcare setting. For public health, surveillance of human and animal health is necessary for tracking and preventing zoonotic diseases. Comparative medicine which is a study of disease processes in different species including human and different animals can be carried out by medical research team and they should promote the study of zoonotic host-agent interactions. Comparative medicine can help in improvisation of prevention and control strategies of Zoonotic diseases.

Track 13: Tracking and preventing Zoonotic diseases

Zoonotic diseases are transferred to humans from animals. It is necessary to take preventive measures to avoid these diseases. This can be achieved by observing the activity of zoonotic diseases in the animals. Monitoring the animals will help in aiming the prevention and control measures for minimizing the impacts of zoonotic diseases on health.

Track 14: Global Zoonotic Disease Surveillance

Regular assessment and updating of the disease is necessary as it can help in finding the best procedures which can help against the zoonotic diseases. A new zoonotic disease can probably emerge from any animal which can be infected or which can remain as a reservoir for zoonotic disease. This has led to the development of the new disease surveillance system that gives best response in spreading the awareness about specific kinds of threats.

Track 15: Industry Analysis

The worldwide flu vaccine market is generally immaculate and can possibly treat any significant episode. The flu vaccine market in the US is the biggest market universally on account of its strong underlying forces and scope of development in the area. The development elements of the market incorporate increment in frequency of H1N1 episodes, rising spending on open social insurance programs, development of the market in rising economies, raising maturing populace and increment in spending on medications and human services consumption. The worldwide flu vaccine market is drifting with improvement of new medications, utilization of new innovations, ascend in FDA endorsements, and increment in productivity rate of flu immunizations, blasting open private organization and developing mindfulness. Be that as it may, the market development will be impeded by complex improvement and creation process, vague process for presentation of new immunizations and high R&D costs.

Track 16: Entrepreneurs in Public Health Care

Increase in livestock diseases and increasing populations has resulted in growth of market. Awareness about vaccination has escalated, but the consequence is higher costs of storage of vaccine has opened gates for many new ideas thus making a way for new entrepreneurs

Track 17: Public Awareness

Public awareness about zoonotic diseases is very important. Awareness can be brought about by gathering the challenges that various healthcare professionals undergo while treating or diagnosing a disease. To understand this, diagnostic dilemma which is associated with zoonotic diseases must be explained properly to the critical audiences. Health care professionals can reach to critical audiences through newspapers, emails, postings, street plays, which can inform them about the preparation during the lambing, calving and the kidding season. Along with these education about agricultural safety practices, may lead in prevention of diseases rather than implying management during crises.

Market Analysis

Around 6001.2 million US$ global therapeutic market was valued in 2016 and was estimated to reach up to 1204.1 million US$ in 2025 increasing the compound annual growth rate of 7.8% from 2017 to 2025. Due to mounting incidences of influenza worldwide, significant increase in global influenza market is expected. The government is in favor of initiating awareness and diagnostic programs which are responsible for the growth of influenza therapeutic market globally.

The considerable economic impact of influenza on the society has resulted in decrease in productivity of caregivers and patients and has increased the use of medical facilities. In 2003 the total economic load related to influenza pandemics was up to US$ 87.1 billion in USA. In February 2013, overall vaccine effectiveness for the year 2012 and 2013 was valued to be about 56%. Global influenza medicine markets which are the key players are Natco Pharma, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Daiichi Sankyo Company, F. Hoffmann-La Roche Ltd., Mylan, Inc. etc. other than these, Roche diagnostics (Switzerland), Quidel (US), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific (US), Luminex corporation (US) etc are also global level companies which are related to influenza diagnostics market. It is estimated that the global diagnostic market will reach up to USD 767.4 million till 2022 from USD 508.8 million in 2016 at a CAGR of 8.6%.  the lagest market for influenza vaccines geographically is north America which has about 50% market share in 2016; Asia being Second largest and Europe being third. Australasia has the least share for the vaccine in 2016.

For the anti-influenza drugs, the medication market is divided into three categories; geography, product and distribution channel type. Distribution channels are divided into hospitals, clinics and pharmacies.

Why Rome?

Around 4 million individuals in Italy have pursued the treatment for influenza in recent weeks which is the maximum number of cases reported since 2004. Between January 8-14 around 83,2000 patients were suffering from flu, and in September 3,883,000 cases in 2007 were monitored by National Health Institute’s virus monitoring service.

Rome is the capital of Italy and also the capital of Lazio region. Rome is the fourth most popular city in European territory on the basis of population in the interior of the city. It is located in the central-western part of Italian peninsula sideways of the shores of Tiber. The Vatican is a country which resides inside Roman boundaries, which is an example of a country inside a city. Rome is considered as a global city, it ranks 14th on the basis of most visited cities. It is listed as world heritage according to UNESCO. Rome hosted Olympics in summer 1960. It is a center for music and has a powerful scene. It also has music theatres and conservatories.

Rome has a number of tourist destinations along with the charm of Rome’s inimitable traditions. Museums; The Vatican Museums, Musei Capitolini and Galleria Borghese are devoted to modern and fashionable art. Churches, Catacombs, historical buildings, fountains, aqueducts, ruins of roman forum and monuments are the other attractions of Rome.

Major Universities on Infectious Diseases Research

Curtin University Curtin Medical School

Western Sydney University School of Medicine

Australian National University Medical School

Melbourne Medical School

University of Adelaide Medical School

University of New South Wales Faculty of Medicine

University of Queensland School of Medicine

James Cook University School of Medicine and Dentistry

Deakin University School of Medicine

Sydney Medical School


Calvary Public Hospital

St Andrew's Hospital

Coonabarabran Hospital

Riverland General Hospital

Kempsey Hospital

Goulburn Base Hospital

Armidale Hospital

National Capital Private Hospital

Bellinger River District Hospital


Research centers

The Australian Centre for Behavioural Research in Diabetes

Centre for Eye Research Australia

Florey Institute of Neuroscience and Mental Health

Melbourne Institute of Applied Economic and Social Research

Walter and Eliza Hall Institute of Medical Research

The Social Research Centre

Hudson Institute of Medical Research

Australia India Institute    

Heart Research Centre


Societies allied with Influenza and Zoonotic Maladies research round the Globe

Clinical Infectious Diseases Society

Edinburgh Infectious Diseases

International Society for Influenza and other Respiratory Virus Diseases

Clinical Infectious Diseases Society

Infectious Diseases Society of America

Society for Zoonotic Ecology and Epidemiology 

European Society of Clinical Microbiology and Infectious Diseases

International Society for Infectious Diseases

European Scientific Counsel Companion Animal Parasites

Australasian Society for Infectious Diseases

European Scientific Working group on Influenza (ESWI)

Ecological Society of America

Industries associated


Bharat Biotech


Gamma Vaccines

bioCSL (CSL)

Sanofi Pasteur

Bavarian Nordic

Chiron Corporation

NovaDigm Therapeutics


Inovio Pharmaceuticals

Immunomic Therapeutics



Novartis Celldex Therapeutics


Emergent BioSolutions


Crucell (Janssen Pharmaceutical)

Indian Immunologicals


MedImmune (AstraZeneca)

Market research on Influenza

Regular flu immunizations in worldwide market are estimated to be 543 million measurements evaluated at US$ 4.9 billion in 2016 and were expected to reach up to US$ 714 million. North America gauged the biggest market; US$7.9 billion till 2016, whereas Europe is estimated as the fastest developing sector for influenza antibodies within 2016-2022 having CAGR 11.7%. Around 80% flu is represented by antibodies whereas the remaining is represented by therapeutics. Therapeutics is considered as the fastest developing section having a CAGR of 11% amongst the previously described investigation.

Market research on Zoonotic Diseases

The development of future market for universal human welfare is depended on majority of zoonotic infection promising interest for human wellbeing items. Awareness among the consumers identified with zoonotic and other transmissible conditions caused by organisms such as Tularemia, Rabies, Q fever etc. has boosted the interest In well beings of humans. According to WHO, about 55,000 individuals from Asia and Africa were suffering from rabies and around USD 590 million was required for their treatment. 13 notable zoonotic conditions which include tuberculosis and bird flu are in custody of about 2.2 million deaths. Specifically, the overall masses is significantly dependent on animal protein, for instance, deplete, meat, eggs and others for their step by step needs, which is required to incite a development in the level of zoonotic diseases in the midst of what's to come. The overall veterinary antibodies exhibit is prepared to accomplish USD 7.68 Billion by 2021 from USD 5.81 Billion out of 2016, at a CAGR of 5.8% from 2016 to 2021. The veterinary vaccinations promote is segmented on the commence of entity, illness, development, and region. The veterinary neutralizer things promote is ordered into accomplice aquaculture vaccinations, porcine vaccinations, animal inoculations, poultry antibodies, tamed creatures antibodies, equine vaccinations, and other animal vaccinations. In this market, accomplice animal antibodies outline the fastest growing thing segment, in view of extending care about vaccination, growing number of zoonotic diseases in the human population, and the growing number of pets and pet proprietors.

Past Conference Report

Influenza 2018

Influenza 2018: Past Conference Report

With the glorious success of the previous conference, Conference Series LLC Ltd hosted 4th International Conference on Influenza and Zoonotic Diseases (Influenza 2018) during July 02-03, 2018 at Vienna, Austria. The conference was marked with the attendance of Editorial Board Members of supported Conference Series LLC Ltd journals, Scientists, young and brilliant Researchers, Business Delegates and talented Student communities representing more than 20 countries, who made this conference fruitful and productive. This conference was based on the theme, “New approaches to outbreak surveillance of Influenza and Zoonotic diseases” which included the following scientific tracks:

  • Influenza Outbreaks
  • Current and Novel Approach for Influenza vaccines
  • Influenza Vaccines and Vaccination
  • Pathogenesis of Influenza Virus
  • Influenza Viruses -Advance in Detection & Differentiation
  • Epidemic Influenza
  • Zoonotic Diseases: Global Infectious Disease Burden
  • Tracking and Preventing Zoonotic Infectious diseases
  • Influenza and other Respiratory Tract Infection Therapy
  • Epidemiology of Zoonotic Influenza
  • Evolution and Epidemiological Aspects of Influenza and Zoonotic Diseases
  • Antiviral treatment for flu and public health policy

We are thankful to our Honourable Guest for their generous support and suggestions:

  • Dr Jaroslav Turanek, Veterinary Research Institute, Czech Republic
  • Dr Joseph Glorioso, Professor, University of Pittsburgh
  • Dr John A Walsh, Professor, University of Warwick, UK
  • Dr. Taijiao Jiang, Director, Center of Biomedical Big Data of Chinese Academy of Medical Sciences, China
  • Dr Alfredo Berzal Herranz, The Institute of Parasitology and Biomedicine "López-Neyra" (IPBLN), Spain


The conference proceedings were carried out through various scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

  1. Development of retargeted ohsv vectors for systemic treatment of breast cancer” given by Joseph C. Glorioso, University of Pittsburgh, USA


  1. The quest for durable plant disease resistance” delivered by John A Walsh, University of Warwick, UK.


  1. Deciphering the information coded by the functional rna domains of the hepatitis c virus genome” delivered by Alfredo Berzal-Herranz, Institute of Parasitology and Biomedicine, Spain


  1. “Noninvasive mucosal vaccination: Recombinant and mRNA vaccine formulation, delivery systems and molecular adjuvants” rendered by Jaroslav Turanek, Veterinary Research Institute, Czech Republic.


  1. “Viral epitranscriptomics”, given by Bryan R Cullen, Duke University Medical Center, USA


  1. “Targeting herpesvirus ribonucleoprotein particle assembly: A novel antiviral strategy”, given by Adrian Whitehouse, University of Leeds, United Kingdom


  1. “Bioinformatic approaches to Infectious Disease”, delivered by Taijiao Jiang, Institute of Basic Medical Sciences-CAMS, China

Conference Sessions Chair:

Joseph C. Glorioso, University of Pittsburgh, USA                                            

Bryan R. Cullen, Duke University Medical Center, USA

Vsevolod A. Zinserling, Saint-Petersburg University, Russia

Conference Series LLC Ltd has taken the privilege of felicitating Influenza 2018 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. The esteemed guests, keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Influenza 2018. We are glad to inform that all accepted abstracts for the conference have been published in Conference Series LLC Journal of Virology & Mycology.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the event, Conference Series LLC Ltd would like to announce the commencement of the “5th International Conference on Influenza and Zoonotic Diseases” to be held during June 17-18, 2019 at Rome, Italy

Let us meet again @ Influenza 2019

For more information please visit:




Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 17-18, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Infectious Diseases & Therapy Journal of Infectious Diseases and Diagnosis Journal of Vaccines & Vaccination Journal of Virology & Mycology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by